Wason

Capturing the real-world benefit of residual $p̆beta$-cell function during clinically important time-periods in established Type 1 diabetes

Designing Multi-arm Multistage Adaptive Trials for Neuroprotection in Progressive Multiple Sclerosis

The role of comorbidities alongside patient and disease characteristics on long-term disease activity in RA using UK inception cohort data

Determining the OPTIMAL DTI analysis method for application in cerebral small vessel disease

Improving power in PSA response analyses of metastatic castration-resistant prostate cancer trials

Response adaptive intervention allocation in stepped-wedge cluster randomized trials

Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials

The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer – a study protocol

Costs and staffing resource requirements for adaptive clinical trials: quantitative and qualitative results from the Costing Adaptive Trials project

Prediction of dementia using diffusion tensor MRI measures: the OPTIMAL collaboration